Janssen Announces U.S. FDA Approval of TREMFYA™ (Guselkumab) for the Treatment is a high-quality image in the Mayo collection, available at 1436 × 2700 pixels resolution — ideal for both digital and print use.
Learn about common side effects of Tremfya, including injection site reactions and infections. Get essential safety information for managing your treatment.
Image Details
| Title | Janssen Announces U.S. FDA Approval of TREMFYA™ (Guselkumab) for the Treatment |
|---|---|
| Dimensions | 1436 × 2700 px |
| Category | Mayo |
| Published | March 23, 2025 |
| Author | Zeus |
| Downloads | 2,323 |
| Views | 127 |
Frequently Asked Questions
This image has a resolution of 1436 × 2700 pixels. It is suitable for high-quality printing, digital presentations, and web use without losing clarity.
This image is part of the Mayo collection. You can browse more images in this category to find similar content.
Click the Download button above the image to save it directly to your device. The image is provided in its original resolution of 1436 × 2700 px.
Yes! Scroll down to the More Images section below to explore related Mayo images. You can also visit the full article for more context and a complete image gallery.
Read full article: Side Effects Of Tremfya